nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS1—Ifosfamide—testicular cancer	0.255	0.255	CbGbCtD
Lumiracoxib—PTGS2—Cisplatin—testicular cancer	0.147	0.147	CbGbCtD
Lumiracoxib—PTGS2—Etoposide—testicular cancer	0.145	0.145	CbGbCtD
Lumiracoxib—CYP2C19—Ifosfamide—testicular cancer	0.124	0.124	CbGbCtD
Lumiracoxib—PTGS1—Etoposide—testicular cancer	0.122	0.122	CbGbCtD
Lumiracoxib—CYP2C9—Ifosfamide—testicular cancer	0.103	0.103	CbGbCtD
Lumiracoxib—CYP1A2—Etoposide—testicular cancer	0.0545	0.0545	CbGbCtD
Lumiracoxib—CYP2C9—Cisplatin—testicular cancer	0.05	0.05	CbGbCtD
